A study assessing the serum microRNAs (miRNAs) of patients asunaprevir/daclatasvir (ASV/DCV) or grazoprevir/elbasvir (GZV/EBV) therapy
Latest Information Update: 28 Aug 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Asunaprevir/daclatasvir
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Aug 2020 New trial record
- 24 Aug 2020 Results published in the Journal of Gastroenterology and Hepatology